{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:46:28Z","timestamp":1767869188048,"version":"3.49.0"},"reference-count":45,"publisher":"Centers for Disease Control MMWR Office","issue":"No. SS-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss6409a1","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T17:43:17Z","timestamp":1444930997000},"page":"1-14","source":"Crossref","is-referenced-by-count":139,"title":["Controlled Substance Prescribing Patterns \u2014 Prescription Behavior Surveillance System, Eight States, 2013"],"prefix":"10.15585","volume":"64","author":[{"given":"Leonard J.","family":"Paulozzi","sequence":"first","affiliation":[{"name":"Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail K.","family":"Strickler","sequence":"additional","affiliation":[{"name":"Prescription Drug Monitoring Program Center for Excellence, Brandeis University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Kreiner","sequence":"additional","affiliation":[{"name":"Prescription Drug Monitoring Program Center for Excellence, Brandeis University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"Koris","sequence":"additional","affiliation":[{"name":"Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R1","unstructured":"CDC. WONDER. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Available at http:\/\/wonder.cdc.gov."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R2","unstructured":"Chen L, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999\u20132011. NCHS Data Brief; 2014. Available at http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db166.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010.","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R4","unstructured":"Substance Abuse and Mental Health Services Administration. The DAWN report: benzodiazepines in combination with opioid pain relievers or alcohol: greater risk of more serious ED visit outcomes. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. Available at http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DAWN-SR192-BenzoCombos-2014\/DAWN-SR192-BenzoCombos-2014.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R5","unstructured":"Substance Abuse and Mental Health Services Administration. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. Available at http:\/\/archive.samhsa.gov\/data\/2k13\/DAWN127\/sr127-DAWN-highlights.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R6","unstructured":"US General Accounting Office. Prescription drugs: state monitoring programs provide useful tool to reduce diversion. Washington, DC: US General Accounting Office; 2002. Available at http:\/\/www.gao.gov\/new.items\/d02634.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15360288.2012.738288","article-title":"The use of prescription monitoring programs to reduce opioid diversion and improve patient safety.","volume":"27","author":"Morgan","year":"2013","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1878","article-title":"Usefulness of prescription monitoring programs for surveillance\u2014analysis of Schedule II opioid prescription data in Massachusetts, 1996\u20132006.","volume":"19","author":"Katz","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R9","unstructured":"Clark T, Eadie J, Kreiner P, Stickler G. Prescription drug monitoring programs: an assessment of the evidence for best practices. Waltham, MA: The Prescription Drug Monitoring Program Center of Excellence at Brandeis University; 2012. Available at http:\/\/www.pdmpexcellence.org\/sites\/all\/pdfs\/Brandeis_PDMP_Report_final.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R10","unstructured":"National Alliance for Model State Drug Laws. Prescription drug monitoring programs. Washington, DC: National Alliance for Model State Drug Laws; 2014. Available at http:\/\/www.namsdl.org\/prescription-monitoring-programs.cfm."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R11","unstructured":"Gunderson C. Prescription Drug Monitoring Programs (PDMPs): Indian Health Service update [Presentation]. Harold Rogers Prescription Drug Monitoring Program Annual Meeting; Washington DC, September 23, 2014. Available at http:\/\/www.pdmpassist.org\/pdf\/PPTs\/National2014\/2-13_Thundercloud.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1345\/aph.1P064","article-title":"Effect of scheduling tramadol as a controlled substance on poison center exposures to tramadol.","volume":"44","author":"Spiller","year":"2010","journal-title":"Ann Pharmacother"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/SMJ.0b013e31826f5310","article-title":"Carisoprodol: update on abuse potential and legal status.","volume":"105","author":"Reeves","year":"2012","journal-title":"South Med J"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death.","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R15","first-page":"648","article-title":"Potential misuse and inappropriate prescription practices involving opioid analgesics.","volume":"19","author":"Liu","year":"2013","journal-title":"Am J Manag Care"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R16","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012.","volume":"63","author":"CDC","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ps.004442012","article-title":"Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008.","volume":"64","author":"McDonald","year":"2013","journal-title":"Psychiatr Serv"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jpain.2012.07.007","article-title":"Geographic variation in opioid prescribing in the U.S.","volume":"13","author":"McDonald","year":"2012","journal-title":"J Pain"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R19","unstructured":"CDC. Summary health statistics for U.S. adults: National Health Interview Survey, 2011. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2012. Available at http:\/\/www.cdc.gov\/nchs\/data\/series\/sr_10\/sr10_256.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey.","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/oby.2009.69","article-title":"How physician obesity specialists use drugs to treat obesity.","volume":"17","author":"Hendricks","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R22","unstructured":"CDC. Health, United States, 2006, with Chartbook. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2006. Available at http:\/\/www.cdc.gov\/nchs\/data\/hus\/hus06.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","article-title":"The descriptive epidemiology of commonly occurring mental disorders in the United States.","volume":"29","author":"Kessler","year":"2008","journal-title":"Annu Rev Public Health"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R24","unstructured":"Chong Y, Fryar C, Gu Q. Prescription sleep aid use among adults: United States, 2005\u20132010. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics, NCHS Data Brief; 2013. Available at http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db127.htm."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/11599460-000000000-00000","article-title":"Medication-related falls in the elderly: causative factors and preventive strategies.","volume":"29","author":"Huang","year":"2012","journal-title":"Drugs Aging"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R26","first-page":"847","article-title":"Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit\/hyperactivity disorder\u2014United States, 2003.","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40268-014-0058-4","article-title":"Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database.","volume":"14","author":"Cepeda","year":"2014","journal-title":"Drugs R D"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose.","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder.","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann Fam Med"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","article-title":"Supply of buprenorphine waivered physicians: the influence of state policies.","volume":"48","author":"Stein","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","article-title":"Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.","volume":"26","author":"Teter","year":"2006","journal-title":"Pharmacotherapy"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.appet.2013.01.008","article-title":"Misuse of prescription stimulants for weight loss, psychosocial variables, and eating disordered behaviors.","volume":"65","author":"Jeffers","year":"2013","journal-title":"Appetite"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R33","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1345\/aph.1P339","article-title":"Carisoprodol legal status and patterns of abuse.","volume":"44","author":"Fass","year":"2010","journal-title":"Ann Pharmacother"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.","volume":"98","author":"Hajak","year":"2003","journal-title":"Addiction"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.forsciint.2014.10.024","article-title":"Trends in licit and illicit drug-related deaths in Florida from 2001 to 2012.","volume":"245C","author":"Lee","year":"2014","journal-title":"Forensic Sci Int"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R36","doi-asserted-by":"crossref","unstructured":"Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007\u20132012. Am J Prev Med 2015; pii: S0749-3797(15)00089-6 [Epub ahead of print].","DOI":"10.1016\/j.amepre.2015.02.020"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R37","first-page":"569","article-title":"Decline in drug overdose deaths after state policy changes\u2014Florida, 2010\u20132012.","volume":"63","author":"Johnson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R38","unstructured":"CDC Public Health Law Program. Menu of pain management clinic regulation. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Available at http:\/\/www.cdc.gov\/phlp\/docs\/menu-pmcr.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R39","unstructured":"Kaiser Commission on Medicaid and the Uninsured. Why does Medicaid spending vary across states: a chart book of factors driving state spending. Washington, DC: Kaiser Family Foundation; 2012. Available at https:\/\/kaiserfamilyfoundation.files.wordpress.com\/2013\/01\/8378.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0091270012436561","article-title":"Opioid shopping behavior: how often, how soon, which drugs, and what payment method.","volume":"53","author":"Cepeda","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","article-title":"Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.","volume":"13","author":"Saunders","year":"2012","journal-title":"J Pain"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11596600-000000000-00000","article-title":"Assessing opioid shopping behavior.","volume":"35","author":"Cepeda","year":"2012","journal-title":"Drug Saf"},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R44","unstructured":"CDC Public Health Law Program. Doctor shopping laws. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Available at http:\/\/www.cdc.gov\/phlp\/docs\/menu-shoppinglaws.pdf."},{"key":"key-10.15585\/mmwr.ss6409a1-201510151334-R45","first-page":"491","article-title":"Decrease in rate of opioid analgesic overdose deaths\u2014Staten Island, New York City, 2011\u20142013.","volume":"64","author":"Paone","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:59:22Z","timestamp":1567267162000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/ss6409a1.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":45,"journal-issue":{"issue":"No. SS-9","published-online":{"date-parts":[[2015,10,16]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss6409a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}